BlackRock Institutional Trust’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

BlackRock Institutional Trust’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-5,094	Closed	-$676K	–	3909
2016 Q3	$676K	Buy	+5,094	New	+$487K	﹤0.01%	3412
2016 Q2	–	Sell	-1,255	Closed	-$91K	–	3982
2016 Q1	$91K	Buy	+1,255	New	+$68.9K	﹤0.01%	3732

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock Institutional Trust's GWPH Position: Q4 2016 in Review

BlackRock Institutional Trust sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2016, closing a stake of 5,094 shares — an estimated $676K sold.

BlackRock Institutional Trust first reported a position in GWPH in Q1 2016 and held it in 2 quarters. The position peaked at $676K in Q3 2016. 164 funds tracked by Wall St. Rank hold GWPH as of Q4 2016.

BlackRock Institutional Trust reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2016 after selling out during the quarter.
BlackRock Institutional Trust sold 5,094 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2016, an estimated $676K.
BlackRock Institutional Trust first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2016 and held it in 2 quarters.
BlackRock Institutional Trust's GW Pharmaceuticals Plc American Depositary Shares position peaked at $676K in Q3 2016.
164 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.